+1-866-732-0305
info@doctorsolve.com
Promising Lead in Cancer Research: Salinomycin Shows Potential to Target Stem Cells
A huge breakthrough has been made in cancer research. Researchers have discovered that a compound called salinomycin killed 100 times more cancer cells than the standard chemotherapy drug (read more on this breast cancer breakthrough).
The study was tested on mice by a team from Boston. Many other experts are hopeful that similar types of treatments could be used to combat other diseases as well.
The findings could essentially pave the way for a treatment that can target cancer stem cells without harming other body cells. The reason to target cancer stem cells is that it is widely believed that cancer stem cells are the reason why cancer is able to come back even after successful treatments to clear tumors.
Obviously, this is a tremendous breakthrough for the entire world. Imagine the possibility that we could develop an anti-cancer drug that would target the cancer, destroy all the stem cells to prevent it from coming back, and all this without harming any other body cells.
Every year, there are around 45,000 women and 300 men diagnosed with breast cancer in Britain alone. Imagine all the lives we could save with this sort of information, and in the meantime, small lifestyle shifts can matter too (see 7 ways to prevent cancer).
Although it will take a few years for researchers to make sure this is safe in humans, the potential is definitely there.
This could be the first step towards finding a cure for cancer, soon to be the number 1 cause of death. In the bigger picture, it’s also worth learning about other cancers and how they’re identified and treated, such as mesothelioma cancer: risks, symptoms & treatment.
Previous Post
